Spots Global Cancer Trial Database for Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)
Official Title: Assessing Tissue Remodeling in the Skin Using Skin Fluorescence Imaging (SFI)
Study ID: NCT03535077
Interventions
Study Description
Brief Summary: The goal of the SFI is to provide non-invasive information about tissue remodeling occurring during melanocytic transition and atypia development in the skin
Detailed Description: The goal of the SFI is to provide non-invasive information about tissue remodeling occurring during melanocytic transition and atypia development in the skin. SFI analyzes the topical staining of the skin surface using the ORL-1 dye to reveal the presence of remodeling in the skin, together with the visible feature characteristics. The system provides a biometric score corresponding to the dye staining, a structural score, and a composite SFI score to quantify the presence of tissue remodeling and the process of melanocytic transition in the skin.
Keywords
Eligibility
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Center for Dermatology Clinical Research, Inc, Fremont, California, United States
UCI Center for Clinical Research, Irvine, California, United States
Divya Railan, Md, Faad, Menlo Park, California, United States
Quest Dermatology Research, Northridge, California, United States
Solano Dermatology Associates, Vallejo, California, United States
University of Utah, Salt Lake City, Utah, United States
Contact Details
Name: Cathy Shachaf, PhD
Affiliation: President
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
